N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide

C105H83F12N29O7 — CID 160630902

IUPACN-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide
SMILESCc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nc(-c2ccncc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2ccoc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(OC(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(OC(F)(F)F)c2)cc1Nc1nc(-c2ccncc2)nc2nc[nH]c12
InChIInChI=1S/C31H30F3N9O.2C25H18F3N7O2.C24H17F3N6O2/c1-19-3-6-23(16-25(19)39-29-26-28(37-18-36-26)40-27(41-29)20-7-9-35-10-8-20)38-30(44)21-4-5-22(24(15-21)31(32,33)34)17-43-13-11-42(2)12-14-43;1-14-7-8-17(32-24(36)15-4-2-6-18(10-15)37-25(26,27)28)11-19(14)33-23-20-22(31-13-30-20)34-21(35-23)16-5-3-9-29-12-16;1-14-5-6-17(32-24(36)16-3-2-4-18(11-16)37-25(26,27)28)12-19(14)33-23-20-22(31-13-30-20)34-21(35-23)15-7-9-29-10-8-15;1-13-5-6-17(30-23(34)14-3-2-4-16(9-14)24(25,26)27)10-18(13)31-22-19-21(29-12-28-19)32-20(33-22)15-7-8-35-11-15/h3-10,15-16,18H,11-14,17H2,1-2H3,(H,38,44)(H2,36,37,39,40,41);2*2-13H,1H3,(H,32,36)(H2,30,31,33,34,35);2-12H,1H3,(H,30,34)(H2,28,29,31,32,33)
InChIKeyRHXJGTGPYODYTH-UHFFFAOYSA-N
MW2090.99 g/mol
LogP22.66
Rot. Bonds24

About N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide

N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide (PubChem CID 160630902) has the molecular formula C105H83F12N29O7 and a molecular weight of 2090.99 g/mol. Its IUPAC name is N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide.

Molecular Properties

Compound NameN-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide
PubChem CID160630902
Molecular FormulaC105H83F12N29O7
Molecular Weight2090.99 g/mol
Exact Mass2089.68
IUPAC NameN-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide
SMILESCc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nc(-c2ccncc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2ccoc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(OC(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(OC(F)(F)F)c2)cc1Nc1nc(-c2ccncc2)nc2nc[nH]c12
InChIInChI=1S/C31H30F3N9O.2C25H18F3N7O2.C24H17F3N6O2/c1-19-3-6-23(16-25(19)39-29-26-28(37-18-36-26)40-27(41-29)20-7-9-35-10-8-20)38-30(44)21-4-5-22(24(15-21)31(32,33)34)17-43-13-11-42(2)12-14-43;1-14-7-8-17(32-24(36)15-4-2-6-18(10-15)37-25(26,27)28)11-19(14)33-23-20-22(31-13-30-20)34-21(35-23)16-5-3-9-29-12-16;1-14-5-6-17(32-24(36)16-3-2-4-18(11-16)37-25(26,27)28)12-19(14)33-23-20-22(31-13-30-20)34-21(35-23)15-7-9-29-10-8-15;1-13-5-6-17(30-23(34)14-3-2-4-16(9-14)24(25,26)27)10-18(13)31-22-19-21(29-12-28-19)32-20(33-22)15-7-8-35-11-15/h3-10,15-16,18H,11-14,17H2,1-2H3,(H,38,44)(H2,36,37,39,40,41);2*2-13H,1H3,(H,32,36)(H2,30,31,33,34,35);2-12H,1H3,(H,30,34)(H2,28,29,31,32,33)
InChIKeyRHXJGTGPYODYTH-UHFFFAOYSA-N
XLogP22.66
TPSA459.11 Ų
H-Bond Donors12
H-Bond Acceptors28
Rotatable Bonds24
Heavy Atoms153
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002090.99
LogP ≤ 522.66
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1028

Analyze N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide?
The IUPAC name of N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide (CID 160630902) is N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide.
What is the SMILES notation for N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide?
The canonical SMILES for N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide is Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nc(-c2ccncc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2ccoc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(OC(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2nc[nH]c12.Cc1ccc(NC(=O)c2cccc(OC(F)(F)F)c2)cc1Nc1nc(-c2ccncc2)nc2nc[nH]c12.
What is the InChIKey of N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide?
The InChIKey is RHXJGTGPYODYTH-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H30F3N9O.2C25H18F3N7O2.C24H17F3N6O2/c1-19-3-6-23(16-25(19)39-29-26-28(37-18-36-26)40-27(41-29)20-7-9-35-10-8-20)38-30(44)21-4-5-22(24(15-21)31(32,33)34)17-43-13-11-42(2)12-14-43;1-14-7-8-17(32-24(36)15-4-2-6-18(10-15)37-25(26,27)28)11-19(14)33-23-20-22(31-13-30-20)34-21(35-23)16-5-3-9-29-12-16;1-14-5-6-17(32-24(36)16-3-2-4-18(11-16)37-25(26,27)28)12-19(14)33-23-20-22(31-13-30-20)34-21(35-23)15-7-9-29-10-8-15;1-13-5-6-17(30-23(34)14-3-2-4-16(9-14)24(25,26)27)10-18(13)31-22-19-21(29-12-28-19)32-20(33-22)15-7-8-35-11-15/h3-10,15-16,18H,11-14,17H2,1-2H3,(H,38,44)(H2,36,37,39,40,41);2*2-13H,1H3,(H,32,36)(H2,30,31,33,34,35);2-12H,1H3,(H,30,34)(H2,28,29,31,32,33).
What are the key properties of N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide?
N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide has a molecular weight of 2090.99 g/mol, XLogP of 22.66, 24 rotatable bonds, 12 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[[2-(furan-3-yl)-7H-purin-6-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[(2-pyridin-3-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide;N-[4-methyl-3-[(2-pyridin-4-yl-7H-purin-6-yl)amino]phenyl]-3-(trifluoromethoxy)benzamide is sourced from PubChem (CID 160630902), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).